|
|
| 产地 | |
| 品牌 | |
| 货号 | |
| 保存条件 | |
| 英文名称 | |
| CAS编号 | |
| 保质期 | 个月 |
用于ee值测定HPLC标记试剂—上海甄准
手性分子的两个对映体中，各对映体都把平面偏振光旋转到一定的角度，其数值相同但方向相反，这种性质称为光学活性。化合物样品的对映体组成可用术语“对映体过量(enantiomeric excess)”或“ee%”来描述。它表示一个对映体对另一个对映体的过量，通常用百分数表示。
上海甄准生物提供用于ee值测定HPLC标记试剂。
产品信息：
| 货号 | 中文品名 | 英文品名 | CAS No | 纯度 | 规格 |
| TOK-A1657 | (1R,2R)-2-(蒽-2,3-二甲酰亚胺基)环己甲酸 | (1R,2R)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid | 446044-44-6 | >980%(T) | 100mg |
| TOK-A1658 | (1S,2S)-2-(蒽-2,3-二甲酰亚胺基)环己甲酸 | (1S,2S)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid | 446044-45-7 | >970%(HPLC) | 100mg |
| TOK-A5514 | 2,3,4,6-四-O-乙酰基-β-D-吡喃葡萄糖异硫氰酸酯 | 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Isothiocyanate [for HPLC Labeling] | 14152-97-7 | >980%(HPLC)(N) | 100mg/1g |
| TOK-A5515 | 2,3,4,6-四-O-苯甲酰基-β-D-吡喃葡萄糖基异硫氰酸酯 | 2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranosyl Isothiocyanate [for HPLC Labeling] | 132413-50-4 | >980%(HPLC) | 100mg/1g |
| TOK-A5523 | Nα-(5-氟-2,4-二硝基苯基)-L-亮氨酰胺 | Nα-(5-Fluoro-2,4-dinitrophenyl)-L-leucinamide [HPLC Labeling Reagent foree Determination] | 178065-29-7 | >980%(HPLC) | 100mg |
| TOK-A5524 | Nα-(2,4-二硝基-5-氟苯基)-D-亮氨酰铵 | Nα-(5-Fluoro-2,4-dinitrophenyl)-D-leucinamide [HPLC Labeling Reagent foree Determination] | 178065-30-0 | >980%(HPLC) | 100mg/1g |
| TOK-A5560 | (S)-(+)-DBD-APy [=(S)-(+)-4-(N,N-二甲氨基磺酰)-7-(3-氨基吡咯烷-1-基)-2,1,3-苯并恶二唑] | (S)-(+)-DBD-APy [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for eeDetermination] | 143112-50-9 | >980%(HPLC) | 100mg |
| TOK-A5561 | (R)-(-)-DBD-APy [=(R)-(-)-4-(N,N-二甲氨基磺酰)-7-(3-氨基吡咯烷-1-基)-2,1,3-苯并恶二唑] | (R)-(-)-DBD-APy [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for eeDetermination] | 143112-49-6 | >980%(HPLC) | 100mg |
| TOK-A5562 | (S)-(+)-NBD-APy [=(S)-(+)-4-硝基-7-(3-氨基吡咯烷-1-基)-2,1,3-苯并恶二唑] | (S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] | 143112-52-1 | >980%(HPLC) | 100mg |
| TOK-A5563 | (R)-(-)-NBD-APy[ =(R)-(-)-4-硝基-7-(3-氨基吡咯烷-1-基)-2,1,3-苯并恶二唑] | (R)-(-)-NBD-APy [=(R)-(-)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] | 143112-51-0 | >980%(HPLC) | 100mg |
| TOK-A5564 | (S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N,N-二甲氨基磺酰基)-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] | (S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] | 150993-63-8 | >900%(HPLC) | 100mg |
| TOK-A5565 | (R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-二甲氨基磺酰基)-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] | (R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] | 150993-62-7 | >950%(HPLC) | 100mg |
| TOK-A5566 | (R)-(+)-NBD-Pro-COCl [=(R)-(+)-4-硝基-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] | (R)-(+)-NBD-Pro-COCl [=(R)-(+)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] | 159717-69-8 | 100mg | |
| TOK-A5567 | (S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-硝基-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] | (S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] | 159717-68-7 | >980%(HPLC) | 100mg |
| TOK-A5568 | (R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N,N-二甲氨基磺酰基)-7-(3-异硫氰酸基四氢吡咯-1-基)-2,1,3-苯并恶二唑] | (R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling] | 163927-31-9 | >980%(HPLC) | 100mg |
| TOK-A5569 | (S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-二甲氨基磺酰基)-7-(3-异硫氰酸基四氢吡咯-1-基)-2,1,3-苯并恶二唑] | (S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling] | 163927-32-0 | >980%(HPLC) | 100mg |
| TOK-A5577 | (R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-异硫氰酸基吡咯烷-1-基)-7-硝基-2,1,3-苯并恶二唑] | (R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] | 163927-29-5 | >980%(HPLC) | 100mg |
| TOK-A5578 | (S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-异硫氰酸基吡咯烷-1-基)-7-硝基-2,1,3-苯并恶二唑] | (S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] | 163927-30-8 | >980%(HPLC) | 100mg |
| TOK-D2259 | Nα-(5-氟-2,4-二硝基苯基)-L-丙氨酰胺 | Nα-(5-Fluoro-2,4-dinitrophenyl)-L-alaninamide [HPLC Labeling Reagent foree Determination] | 95713-52-3 | >950%(HPLC) | 100mg/1g |
| TOK-I0334 | (R)-(+)-α-甲基苄基异氰酸酯 | (R)-(+)-α-Methylbenzyl Isocyanate | 33375-06-3 | >980%(GC) | 1g/5g/25g |
| TOK-I0335 | 异氰酸(S)-(-)-α-甲基苄酯 | (S)-(-)-α-Methylbenzyl Isocyanate | 14649-03-7 | >950%(GC) | 1g/5g |
| TOK-I0336 | 异氰酸(R)-(-)-1-(萘基)乙酯 | (R)-(-)-1-(1-Naphthyl)ethyl Isocyanate | 42340-98-7 | >900%(GC) | 1g/5g |
| TOK-I0398 | 异氰酸(S)-(+)-1-(1-萘基)乙酯 | (S)-(+)-1-(1-Naphthyl)ethyl Isocyanate | 73671-79-1 | >950%(GC) | 1g/5g |
| TOK-M1366 | (R)-(-)-2-甲氧基-2-(1-萘基)丙酸 | (R)-(-)-2-Methoxy-2-(1-naphthyl)propionic Acid | 63628-26-2 | >990%(HPLC) | 100mg |
| TOK-M1367 | (S)-(+)-2-甲氧基-2-(1-萘基)丙酸 | (S)-(+)-2-Methoxy-2-(1-naphthyl)propionic Acid | 102691-93-0 | >990%(HPLC) | 100mg |
| TOK-N0713 | (1R,2R)-2-(萘-2,3-二甲酰亚胺基)环己甲酸 | (1R,2R)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid | 642995-15-1 | >980%(HPLC)(T) | 100mg |
| TOK-N0714 | (1S,2S)-2-(萘-2,3-二甲酰亚胺基)环己甲酸 | (1S,2S)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid | 642995-16-2 | >980%(HPLC)(T) | 100mg |
客服热线/QQ：4000023832
